Market Tracker

10/30 7:05pm ET

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

192.93
Data as of Oct 30
 +2.44 / +1.28%
Today’s Change
113.14
Today|||52-Week Range
194.20
+45.19%
Year-to-Date

Today’s Trading

Previous close190.49
Today’s open190.21
Day’s range189.15 - 194.20
Volume1,146,377
Average volume (3 months)1,160,645
Market cap$37.8B
Dividend yield--
Data as of 3:59pm ET, 10/30/2014

Growth & Valuation

Earnings growth (last year)-0.78%
Earnings growth (this year)+68.50%
Earnings growth (next 5 years)+25.70%
Revenue growth (last year)+34.85%
P/E ratio80.4
Price/Sales17.19
Price/Book15.75

Competitors

 Today’s
change
Today’s
% change
SHPGShire PLC+2.97+1.51%
VRXValeant Pharmaceutic...+1.75+1.35%
VRTXVertex Pharmaceutica...+0.94+0.86%
PRGOPerrigo Company PLC+6.33+4.08%
Data as of 4:03pm ET, 10/30/2014

Financials

Last reporting dateOctober 23, 2014
EPS forecast (this quarter)$1.27
Annual revenue (last year)$1.5B
Annual profit (last year)$252.9M
Net profit margin16.73%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, CEO, Treasurer &
Director
Leonard Bell
Chief Operating Officer &
Director
David L. Hallal
Corporate headquarters
Cheshire, Connecticut

Forecasts